
Bunge Limited (BG) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
12.8B
Gross Profit
738.0M
5.78%
Operating Income
320.0M
2.51%
Net Income
370.0M
2.90%
EPS (Diluted)
$2.61
Balance Sheet Metrics
Total Assets
26.7B
Total Liabilities
15.1B
Shareholders Equity
11.6B
Debt to Equity
1.30
Cash Flow Metrics
Operating Cash Flow
-1.1B
Free Cash Flow
-595.0M
Revenue & Profitability Trend
Bunge Limited Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 53.1B | 59.5B | 67.2B | 59.2B | 41.4B |
Cost of Goods Sold | 49.7B | 54.7B | 63.6B | 55.8B | 38.6B |
Gross Profit | 3.4B | 4.8B | 3.7B | 3.4B | 2.8B |
Gross Margin % | 6.4% | 8.1% | 5.5% | 5.7% | 6.7% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 1.8B | 1.7B | 1.4B | 1.2B | 1.4B |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 1.8B | 1.7B | 1.4B | 1.2B | 1.4B |
Operating Income | 1.6B | 3.1B | 2.3B | 2.1B | 1.4B |
Operating Margin % | 3.0% | 5.3% | 3.4% | 3.6% | 3.4% |
Non-Operating Items | |||||
Interest Income | 163.0M | 148.0M | 71.0M | 48.0M | 22.0M |
Interest Expense | 471.0M | 516.0M | 403.0M | 243.0M | 265.0M |
Other Non-Operating Income | 215.0M | 289.0M | 85.0M | 631.0M | 229.0M |
Pre-tax Income | 1.5B | 3.1B | 2.1B | 2.6B | 1.4B |
Income Tax | 336.0M | 714.0M | 388.0M | 398.0M | 248.0M |
Effective Tax Rate % | 22.0% | 23.4% | 18.8% | 15.5% | 17.6% |
Net Income | 1.2B | 2.3B | 1.7B | 2.2B | 1.2B |
Net Margin % | 2.2% | 3.9% | 2.5% | 3.7% | 2.8% |
Key Metrics | |||||
EBITDA | 2.7B | 4.0B | 2.9B | 3.3B | 2.0B |
EPS (Basic) | $8.49 | $15.07 | $10.74 | $14.49 | $8.02 |
EPS (Diluted) | $7.99 | $14.87 | $10.51 | $13.64 | $7.71 |
Basic Shares Outstanding | 133964235 | 148804387 | 149907932 | 141057414 | 139790238 |
Diluted Shares Outstanding | 133964235 | 148804387 | 149907932 | 141057414 | 139790238 |
Income Statement Trend
Bunge Limited Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.3B | 2.6B | 1.1B | 902.0M | 352.0M |
Short-term Investments | 484.0M | 105.0M | 119.0M | 520.0M | 346.0M |
Accounts Receivable | 2.1B | 2.6B | 2.8B | 2.1B | 1.7B |
Inventory | 6.5B | 7.1B | 8.4B | 8.4B | 7.2B |
Other Current Assets | 434.0M | 265.0M | 386.0M | 198.0M | 147.0M |
Total Current Assets | 16.0B | 16.4B | 16.8B | 16.5B | 16.2B |
Non-Current Assets | |||||
Property, Plant & Equipment | 932.0M | 926.0M | 1.0B | 912.0M | 868.0M |
Goodwill | 1.2B | 1.4B | 1.3B | 1.4B | 1.7B |
Intangible Assets | 321.0M | 398.0M | 360.0M | 431.0M | 529.0M |
Long-term Investments | 0 | 1.0M | 1.0M | 49.0M | 111.0M |
Other Non-Current Assets | 1.0B | 1.2B | 1.2B | 1.0B | 823.0M |
Total Non-Current Assets | 8.9B | 9.0B | 7.8B | 7.4B | 7.5B |
Total Assets | 24.9B | 25.4B | 24.6B | 23.8B | 23.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 2.8B | 3.7B | 4.4B | 4.2B | 2.6B |
Short-term Debt | 1.8B | 1.1B | 1.8B | 1.5B | 3.1B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.3B | 1.3B | 1.9B | 2.3B | 4.0B |
Total Current Liabilities | 7.4B | 7.7B | 9.6B | 9.3B | 11.0B |
Non-Current Liabilities | |||||
Long-term Debt | 5.3B | 4.6B | 3.8B | 5.3B | 5.0B |
Deferred Tax Liabilities | 379.0M | 400.0M | 365.0M | 338.0M | 360.0M |
Other Non-Current Liabilities | 164.0M | 176.0M | 160.0M | 195.0M | 199.0M |
Total Non-Current Liabilities | 6.5B | 5.9B | 5.0B | 6.3B | 6.0B |
Total Liabilities | 14.0B | 13.6B | 14.6B | 15.6B | 17.0B |
Equity | |||||
Common Stock | 1.0M | 0 | 1.0M | 1.0M | 1.0M |
Retained Earnings | 12.8B | 12.1B | 10.2B | 9.0B | 7.2B |
Treasury Stock | 1.5B | 1.1B | 1.3B | 1.1B | 1.0B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 10.9B | 11.8B | 10.0B | 8.2B | 6.6B |
Key Metrics | |||||
Total Debt | 7.1B | 5.8B | 5.6B | 6.8B | 8.1B |
Working Capital | 8.5B | 8.7B | 7.2B | 7.1B | 5.2B |
Balance Sheet Composition
Bunge Limited Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.2B | 2.3B | 1.7B | 2.2B | 1.2B |
Depreciation & Amortization | 468.0M | 451.0M | 408.0M | 424.0M | 435.0M |
Stock-Based Compensation | 65.0M | 69.0M | 65.0M | 61.0M | 71.0M |
Working Capital Changes | 426.0M | 1.7B | -7.7B | -5.0B | -5.0B |
Operating Cash Flow | 2.2B | 4.7B | -5.6B | -2.6B | -3.2B |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | 675.0M | 34.0M | 453.0M | 601.0M | 180.0M |
Investment Purchases | -1.3B | -133.0M | -456.0M | -342.0M | -337.0M |
Investment Sales | 958.0M | 49.0M | 326.0M | 171.0M | 370.0M |
Investing Cash Flow | 262.0M | 113.0M | 7.1B | 5.5B | 2.2B |
Financing Activities | |||||
Share Repurchases | -1.1B | -600.0M | -200.0M | -100.0M | -100.0M |
Dividends Paid | -378.0M | -383.0M | -349.0M | -323.0M | -316.0M |
Debt Issuance | 2.0B | 978.0M | 297.0M | 1.0B | 2.4B |
Debt Repayment | -1.8B | -2.2B | -2.9B | -4.6B | -34.0B |
Financing Cash Flow | -1.2B | -1.9B | -2.7B | -6.4B | -30.1B |
Free Cash Flow | 524.0M | 2.2B | -6.1B | -3.3B | -3.9B |
Net Change in Cash | 1.3B | 3.0B | -1.2B | -3.5B | -31.1B |
Cash Flow Trend
Bunge Limited Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
8.36
Forward P/E
8.92
Price to Book
1.02
Price to Sales
0.33
PEG Ratio
8.92
Profitability Ratios
Profit Margin
2.71%
Operating Margin
2.80%
Return on Equity
12.53%
Return on Assets
3.14%
Financial Health
Current Ratio
2.06
Debt to Equity
102.15
Beta
0.65
Per Share Data
EPS (TTM)
$9.92
Book Value per Share
$80.95
Revenue per Share
$372.89
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
bg | 16.6B | 8.36 | 1.02 | 12.53% | 2.71% | 102.15 |
Archer-Daniels-Midla | 27.8B | 25.15 | 1.24 | 4.82% | 1.33% | 46.80 |
Tyson Foods | 20.3B | 25.93 | 1.11 | 4.43% | 1.45% | 49.09 |
Smithfield Foods | 10.0B | 11.25 | 1.61 | 15.73% | 7.06% | 36.10 |
Cal-Maine Foods | 5.2B | 4.32 | 2.04 | 55.84% | 28.63% | 0.00 |
Vital Farms | 2.0B | 40.61 | 6.56 | 18.81% | 7.84% | 5.68 |
Financial data is updated regularly. All figures are in the company's reporting currency.